| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |